Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for lower gastrointestinal bleeding
ACTRN12611000865910Phase 3Completed
- Sponsor
- John Hunter Hospital
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anorectal bleeding comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Blood loss as assessed by reduction in haemoglobin concentration. Started Nov 2011; status: completed.
02
Drugs
tranexamic acid
03
Conditions
anorectal bleeding
Beyond the preview
Go deeper on ACTRN12611000865910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000865910.